Rituximab as a ''chemo-equalizer'' in the MInT (Mabthera International Trial Group) study: Treatment results of CHOP-21, CHOEP-21, MACOP-B and PMiTCEBO with and without Rituximab in young good-prognosis patients with aggressive lymphomas